Enzo Biochem, Inc. (ENZ) has received an expansion of its Emergency Use Authorization from the FDA authorizing the use of pooled samples containing up to five individual swab specimens with the AMPIPROBE SARS-Cov-2 Test System utilizing tests on three different platforms including Enzo's GENFLEX automated high-throughput platform.
"This expansion of the EUA to include pooled samples can rapidly expand testing capacity based on ENZO's proven, reliable and sensitive PCR-based molecular test for SARS-Cov-2," said Elazar Rabbani, Enzo CEO.
Shares of Enzo Biochem were up 11% in pre-market trade on Monday.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.